登録して招待リンクを共有すると、動画再生報酬と紹介報酬を獲得できます。

AIM ImmunoTech
@AimImmuno
We are an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders.
参加 August 2019
356 フォロー中    3.5K ファン
AIM ImmunoTech Completes Phase 2 DURIPANC Enrollment Milestone Ahead of Schedule, Advancing Ampligen Toward Critical Pancreatic Cancer Clinical Milestones